The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations.
Kirkpatrick BD, Tenney KM, Larsson CJ, O'Neill JP, Ventrone C, Bentley M, Upton A, Hindle Z, Fidler C, Kutzko D, Holdridge R, Lapointe C, Hamlet S, Chatfield SN.
Kirkpatrick BD, et al. Among authors: hamlet s.
J Infect Dis. 2005 Aug 1;192(3):360-6. doi: 10.1086/431605. Epub 2005 Jun 30.
J Infect Dis. 2005.
PMID: 15995948
Clinical Trial.